Prevalence and Clinical Impact of SARS‐CoV‐2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID‐19 Pandemic

INTRODUCTION: In Europe, the SARS‐CoV‐2 pandemic had its first epicenter in Italy. Despite a significant mortality rate, the severity of most cases of COVID‐19 infection ranges from asymptomatic to mildly symptomatic, and silent infection affects a still‐unknown proportion of the general population....

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncologist
المؤلفون الرئيسيون: Zambelli, Alberto, Chiudinelli, Lorenzo, Fotia, Vittoria, Negrini, Giorgia, Bosetti, Tommaso, Callegaro, Annapaola, Di Croce, Andrea, Caremoli, Elena Rota, Moro, Cecilia, Milesi, Laura, Poletti, Paola, Tasca, Cristina, Mandalà, Mario, Merelli, Barbara, Mosconi, Stefania, Arnoldi, Ermenegildo, Bettini, Anna, Bonomi, Lucia, Messina, Caterina, Ghilardi, Laura, Chirco, Alessandra, Maracino, Michela, Tondini, Carlo
التنسيق: Artigo
اللغة:Inglês
منشور في: John Wiley & Sons, Inc. 2021
الموضوعات:
Symptom Management and Supportive Care
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018331/
https://ncbi.nlm.nih.gov/pubmed/33355953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13654
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة